it takes two to tango. First, Joe should know better...he

New Post Public Reply Private Reply Replies (0) Message Board
Cody760 hylander #30033
459
it takes two to tango.
First, Joe should know better...he should. know. better....than to get mixed up in such a lose/lose conversation on social media, including this board. He’s young enough to be my son. And so I say, ‘son, don’t do that again. Ever. You only hurt yourself.’ And Joe, for your own sake, and I do mean you well, I’d recommend that you avoid this board like your life depended on it: when you show up here people might be looking to put a target on your back. No need for that. Life is hard enough just running a struggling company.

Professionally, there’s only so much ANY ceo can say in this environment. The only reasonable answers are, ‘I don’t know’, ‘I can’t comment on that’, or ‘email investor relations with your comments or questions’. Period.

Anyone who is trying to get a concrete answer from a ceo on social media is barking up the wrong tree. You’re destined to be disappointed. And frustrated. And if you get frustrated, looking for concrete answers, just know that it’s self-inflicted misery.

And lastly, and I am not making an accusation, but IF one were to plan to discredit a ceo or a company by drawing management into an embarrassing public exchange, well, we just got an effective lesson into how to do that. IF one were trying to do that, I’d have to say ‘well done!’

Let’s hope for more useful exchanges during the remainder of the GNBT journey.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Early Career Challenges: Strategies for Success

Updated Category News Views 159

Understanding the Challenges of Early Career Professionals As the new generation of professionals prepares to step into the workforce, they often face a variety of challenges. Recent insights from professionals reveal common hurdles that individuals might encounter early in their careers. Understanding these challenges is the first step toward successfully navigating...

Continue Reading
Pharming Takes Strategic Step with Public Offer for Abliva AB

Updated Category News Views 387

Pharming Sets a New Course with Strategic Acquisition Strengthening the Pipeline with a First-in-Disease Asset Pharming Group N.V. has recently made headlines with its ambitious public cash offer for Abliva AB. This strategic acquisition, valued at approximately US$66.1 million, aims to advance Pharming's late-stage pipeline significantly. At the heart of this acquisition...

Continue Reading
Golden Sun Health Tech Launches Joint Venture in Tourism Sector

Updated Category News Views 113

Golden Sun Health Technology Group Limited Ventures into Cultural Tourism Golden Sun Health Technology Group Limited, previously known as Golden Sun Education Group Limited (NASDAQ: GSUN), has made a notable step forward by launching a joint venture aimed at tapping into the cultural tourism market. Through its wholly-owned subsidiary, Shanghai Golden Sun Gongyu Education...

Continue Reading
BlackRock Municipal Income Fund Announces Merger Dates and Changes

Updated Category News Views 520

BlackRock Municipal Income Fund Transition Announcement BlackRock Municipal Income Fund, Inc. (NYSE: MUI, referred to as the “Fund”) is set to undergo an exciting transition. The Fund will change from an exchange-listed closed-end fund to an unlisted continuously-offered closed-end fund, which will conduct quarterly repurchases of its shares. This new venture will be...

Continue Reading
Understand Your Rights: Join CrowdStrike Class Action Today

Updated Category News Views 152

Understanding the CrowdStrike Holdings Class Action Attention shareholders of CrowdStrike Holdings, Inc. (NASDAQ: CRWD): If you acquired shares during the specified class period, it’s important to understand your rights regarding an ongoing class action. Recent developments have raised concerns about the company's operations, particularly in relation to its flagship...

Continue Reading